Collegium Pharmaceutical ... (COLL)
NASDAQ: COLL
· Real-Time Price · USD
38.19
0.56 (1.49%)
At close: Aug 20, 2025, 12:50 PM
1.49% (1D)
| Bid | 38.16 |
| Market Cap | 1.2B |
| Revenue (ttm) | 664.28M |
| Net Income (ttm) | 43.89M |
| EPS (ttm) | 1.06 |
| PE Ratio (ttm) | 36.03 |
| Forward PE | 5.15 |
| Analyst | Buy |
| Ask | 38.36 |
| Volume | 117,350 |
| Avg. Volume (20D) | 317,758 |
| Open | 37.56 |
| Previous Close | 37.63 |
| Day's Range | 37.29 - 38.20 |
| 52-Week Range | 23.23 - 42.29 |
| Beta | 0.68 |
About COLL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COLL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COLL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Collegium Pharmaceutical Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+2.22%
Collegium Pharmaceuticals shares are trading highe...
Unlock content with
Pro Subscription
5 months ago
+0.25%
Collegium Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 financial results.
